Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global Hodgkin’s lymphoma treatment market reached a value of about USD 1.41 billion in 2023. The market is further estimated to grow at a CAGR of 13.20% in the forecast period of 2024-2032 to reach a value of around USD 4.31 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the treatment type, the radiotherapy segment holds significant market share of Hodgkin’s lymphoma treatment. The growing awareness about the effectiveness of radiotherapy in killing Hodgkin’s lymphoma cells is contributing to the steady market growth. Radiotherapy is painless, and the treatment is administered in short sessions that require no hospital stay, thereby accelerating the market development. In addition, radiotherapy can be given along with surgery, chemotherapy, hormones, or targeted therapy, which offers the patients with wide choices to treat the disease completely, thus bolstering the market. The availability of modern imaging tests that enables the doctors to aim at the lymphoma sites precisely can help limit side effects, which plays a critical role in expanding the market for Hodgkin’s lymphoma treatment. The rising inclination of healthcare professionals towards newer approaches to radiation, such as Involved site radiation therapy (ISRT), which reduces the size of the treatment area and helps spare nearby normal tissues from getting radiation, is leading to the market growth of Hodgkin’s lymphoma treatment.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Hodgkin’s lymphoma is a type of cancer that spreads through the lymph vessels from lymph node to lymph node. The cancer in an advanced stage, though rarely, can invade the bloodstream and spread to other body parts, such as the liver, lungs, and bone marrow. There are two types of Hodgkin’s lymphoma - Classic Hodgkin lymphoma (cHL) and Nodular lymphocyte. The predominant treatments offered to cure the disease are chemotherapy, and radiotherapy, among others.
The market for Hodgkin’s lymphoma treatment, by treatment type, is divided into:
The regional markets for Hodgkin’s lymphoma treatment can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing prevalence of Hodgkin’s Lymphoma disease is leading to the market development of Hodgkin’s Lymphoma treatment. In 2019, about 218,740 people were living with Hodgkin lymphoma in the United States, and the region witnessed an estimated increase of 8,540 cases in 2023. The developing healthcare infrastructure and the rapid diagnosis of the disease are contributing to the market expansion of Hodgkin’s Lymphoma treatment. The growing awareness about the increased recovery chance of the disease among the people and the importance of treatments in it is further propelling the market for Hodgkin’s Lymphoma treatment. The government initiatives in approving novel drugs to treat Hodgkin’s Lymphoma play a critical role in expanding the market. In 2018, the U.S. FDA approved Adcetris (brentuximab vedotin) to treat adult patients with earlier untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with chemotherapy. The development of efficient therapies due to the research activities and the rising clinical trials is expected to augment the market for Hodgkin’s lymphoma treatment over the forecast period.
The report gives a detailed analysis of the following key players in the global Hodgkin’s lymphoma treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Treatment Type |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2023, the global Hodgkin’s lymphoma treatment market attained a value of nearly USD 1.41 billion.
The market is assessed to grow at a CAGR of 13.20% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach almost USD 4.31 billion by 2032.
The major market drivers include the increased recovery chances through effective treatments, rapid diagnosis of the disease, developing healthcare infrastructure, and growing awareness about the different treatments available to cure the disease.
The key market trends include government initiatives in approving drugs, and research activities done to develop new therapies and drugs.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The various treatment types of Hodgkin’s lymphoma treatment, include chemotherapy, and radiotherapy, among others.
The major players in the market are Alkem Laboratories, Amneal Pharmaceuticals, Inc., Baxter International Inc., Biogen Inc., Bristol-Myers Squibb Company, F Hoffmann-La Roche Ltd, and Incyte Corp., among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share